Allicin lowered the elevated levels of oxidative stress (JNK/c-jun-dependent), which are strictly connected to AD pathology, thus reducing mitochondrial dysfunction [90] (Table 1). This evidence concerns the gene MAPK8 and Alzheimer disease.